Skip to main content
Livermore
Livermore
ZHEN

Newtyn Management, LLC

SEC CIK
0001569241
Latest filing
Aug 14, 2026

The latest 13F from Newtyn Management, LLC covers Q2 2026 (filed Aug 14, 2026): 34 long positions worth $800.9M. The top 10 holdings make up 61.9% of the portfolio, and the largest is QuidelOrtho Corp (QDEL) at 14.5%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
7
Est. +$112.0M
Added
7
Est. +$63.7M
Reduced
14
Est. −$127.5M
Sold out
6
Est. −$230.9M

Top 5 holdings

Share of this quarter's portfolio value

  1. QDELQuidelOrtho Corp
    14.5%$116.0MHistory
  2. TBPHTheravance Biopharma, Inc.
    7.3%$58.4MHistory
  3. INDVIndivior Pharmaceuticals, Inc.
    6.7%$53.6MHistory
  4. CNNECannae Holdings, Inc.
    5.7%$45.6MHistory
  5. PARPar Technology Corp
    5.3%$42.1MHistory

Share of portfolio

Top 5 holdings and the other 29 positions, by share of portfolio value

  1. QDEL14.5%
  2. TBPH7.3%
  3. INDV6.7%
  4. CNNE5.7%
  5. PAR5.3%
  6. Other 29 positions60.6%

Biggest buys

New and added positions, by estimated amount bought

  1. QDELQuidelOrtho Corp
    +$36.2MAddedHistory
  2. OCTVOctave Intelligence plc
    +$31.3MNewHistory
  3. XOMAXOMA Royalty Corp
    +$30.1MNewHistory
  4. PSIXPower Solutions International, Inc.
    +$23.4MNewHistory
  5. XRNChiron Real Estate Inc.
    +$15.2MNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. QDELQuidelOrtho Corp
    +6.48 pp8.0% → 14.5%History
  2. OCTVOctave Intelligence plc
    +3.91 pp0.0% → 3.9%History
  3. XOMAXOMA Royalty Corp
    +3.76 pp0.0% → 3.8%History
  4. PSIXPower Solutions International, Inc.
    +2.92 pp0.0% → 2.9%History
  5. XRNChiron Real Estate Inc.
    +1.90 pp0.0% → 1.9%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. NVRIEnviri Corp
    −$108.0MSold outHistory
  2. VISNVistance Networks, Inc.
    −$68.5MSold outHistory
  3. ADArray Digital Infrastructure, Inc.
    −$37.0MReducedHistory
  4. USARUSA Rare Earth, Inc.
    −$35.4MSold outHistory
  5. INDVIndivior Pharmaceuticals, Inc.
    −$28.5MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. NVRIEnviri Corp
    −11.54 pp11.5% → 0.0%History
  2. VISNVistance Networks, Inc.
    −7.32 pp7.3% → 0.0%History
  3. ADArray Digital Infrastructure, Inc.
    −5.27 pp8.0% → 2.7%History
  4. USARUSA Rare Earth, Inc.
    −3.78 pp3.8% → 0.0%History
  5. TBPHTheravance Biopharma, Inc.
    −1.11 pp8.4% → 7.3%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$800.9M
−$134.9M (−14.4%) vs. prior quarter
Positions
34
+1 vs. prior quarter
Top 10 concentration
61.9%
Top 10 as share of value
Turnover
20.2%
Q2 2026, one quarter
Average holding period
8.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $945.3M (Q4 2025)

Q1 2021: $370.4MQ2 2021: $361.2MQ3 2021: $374.9MQ4 2021: $376.7MQ1 2022: $417.6MQ2 2022: $527.8MQ3 2022: $455.5MQ4 2022: $484.6MQ1 2023: $508.9MQ2 2023: $423.3MQ3 2023: $405.2MQ4 2023: $509.4MQ1 2024: $502.0MQ2 2024: $532.6MQ3 2024: $651.5MQ4 2024: $574.3MQ1 2025: $632.1MQ2 2025: $660.0MQ3 2025: $816.9MQ4 2025: $945.3MQ1 2026: $935.8MQ2 2026: $800.9M
Q1 2021Q2 2026
13F filings of Newtyn Management, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202634$800.9MQDELTBPHINDVvs. Q1 2026SEC
Q1 2026May 15, 202633$935.8MNVRITBPHQDELvs. Q4 2025SEC
Q4 2025Feb 17, 202631$945.3MADINDVQDELvs. Q3 2025SEC
Q3 2025Nov 14, 202533$816.9MINDVQDELTBPHvs. Q2 2025SEC
Q2 2025Aug 14, 202534$660.0MCNNETBPHQDELvs. Q1 2025SEC
Q1 2025May 15, 202531$632.1MCNNEPPLIMRPvs. Q4 2024SEC
Q4 2024Feb 14, 202533$574.3MPPLIQDELTBPHvs. Q3 2024SEC
Q3 2024Nov 14, 202440$651.5MPPLIQDELCCOIvs. Q2 2024SEC
Q2 2024Aug 14, 202440$532.6MPPLIPARQDELvs. Q1 2024SEC
Q1 2024May 15, 202440$502.0MPPLIPARCNNEvs. Q4 2023SEC
Q4 2023Feb 14, 202448$509.4MCNNEPPLIPARvs. Q3 2023SEC
Q3 2023Nov 14, 202346$405.2MCNNEPPLIPARvs. Q2 2023SEC
Q2 2023Aug 14, 202346$423.3MPPLICNNEGIIIvs. Q1 2023SEC
Q1 2023May 15, 202380$508.9MPPLIPARAMBPvs. Q4 2022SEC
Q4 2022Feb 14, 202371$484.6MPPLIAMBPAVTAvs. Q3 2022SEC
Q3 2022Nov 14, 202280$455.5MAMBPAVTAPARvs. Q2 2022SEC
Q2 2022Aug 15, 202284$527.8MPARAMBPAVTAvs. Q1 2022SEC
Q1 2022May 16, 202239$417.6MPARAVTATSVTvs. Q4 2021SEC
Q4 2021Feb 14, 202235$376.7MONLSPBMBIvs. Q3 2021SEC
Q3 2021Nov 15, 202137$374.9MEBCRFLSPBvs. Q2 2021SEC
Q2 2021Aug 16, 202190$361.2MEBCSTMPSPBvs. Q1 2021SEC
Q1 2021May 17, 2021102$370.4MEBCGLNGCPLG–SEC

13D and 13G filings

Companies where Newtyn Management, LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

13 companies, largest stake first.

Companies where Newtyn Management, LLC owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
QDELQuidelOrtho Corp13G/A9.70%6.63M shares+1.90 ppfrom 7.80%May 6, 20263 filingsAug 14, 2026SEC
FLWS1 800 Flowers Com Inc13G/A9.60%3.50M shares+1.50 ppfrom 8.10%Nov 10, 20253 filingsFeb 17, 2026SEC
USARUSA Rare Earth, Inc.13G8.30%700.0K sharesNewJan 7, 20251 filingJan 7, 2025SEC
AIVApartment Investment & Management Co13G/A8.10%11.6M shares+2.60 ppfrom 5.50%Nov 14, 20252 filingsMar 25, 2026SEC
WEAVWeave Communications, Inc.13G8.00%6.31M sharesNewMar 20, 20261 filingMar 20, 2026SEC
ARIApollo Commercial Real Estate Finance, Inc.13G7.90%10.3M sharesNewJul 30, 20261 filingJul 30, 2026SEC
MAGNMagnera Corp13G/A7.70%2.76M shares+1.30 ppfrom 6.40%Aug 14, 20252 filingsMay 15, 2026SEC
CNNECannae Holdings, Inc.13G/A7.60%3.55M shares+1.50 ppfrom 6.10%May 15, 20253 filingsFeb 17, 2026SEC
CIOCity Office REIT, Inc.13G/A6.90%2.80M shares–Feb 14, 20243 filingsFeb 17, 2026SEC
TBPHTheravance Biopharma, Inc.13G/A6.70%3.43M shares−1.80 ppfrom 8.50%Aug 16, 20244 filingsAug 14, 2026SEC
ZOOZZOOZ Strategy Ltd.13G/A6.60%537.5K shares−2.00 ppfrom 8.60%Feb 17, 20262 filingsAug 14, 2026SEC
NVRIEnviri Corp13G6.20%5.00M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC
PARPar Technology Corp13G/A5.50%2.25M shares−1.10 ppfrom 6.60%May 15, 20262 filingsAug 14, 2026SEC

Latest filings

55 filings on file made by Newtyn Management, LLC or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Newtyn Management, LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
PARPar Technology CorpAug 14, 20264:15 PM ET13G/A5.50%2.25M shares−1.10 ppfrom 6.60%Jun 30, 2026SEC
ZOOZZOOZ Strategy Ltd.Aug 14, 20264:15 PM ET13G/A6.60%537.5K shares−2.00 ppfrom 8.60%Jun 30, 2026SEC
QDELQuidelOrtho CorpAug 14, 20264:15 PM ET13G/A9.70%6.63M shares+1.90 ppfrom 7.80%Jun 30, 2026SEC
NVRIEnviri CorpAug 14, 20264:15 PM ET13G/A1.30%374.2K shares–Below 5%Jun 30, 2026SEC
TBPHTheravance Biopharma, Inc.Aug 14, 20264:15 PM ET13G/A6.70%3.43M shares−1.80 ppfrom 8.50%Jun 30, 2026SEC
ARIApollo Commercial Real Estate Finance, Inc.Jul 30, 20264:15 PM ET13G7.90%10.3M sharesNewJul 23, 2026SEC
PARPar Technology CorpMay 15, 20264:15 PM ET13G6.60%2.73M sharesNewMar 31, 2026SEC
MAGNMagnera CorpMay 15, 20264:15 PM ET13G/A7.70%2.76M shares+1.30 ppfrom 6.40%Mar 31, 2026SEC
QDELQuidelOrtho CorpMay 6, 20264:20 PM ET13G/A7.80%5.30M shares+1.10 ppfrom 6.70%Apr 29, 2026SEC
QDELQuidelOrtho CorpMay 6, 20264:15 PM ET13G6.70%4.56M sharesNewMar 31, 2026SEC
AIVApartment Investment & Management CoMar 25, 20264:30 PM ET13G/A8.10%11.6M shares+2.60 ppfrom 5.50%Mar 18, 2026SEC
WEAVWeave Communications, Inc.Mar 20, 20264:30 PM ET13G8.00%6.31M sharesNewMar 13, 2026SEC
CIOCity Office REIT, Inc.Feb 17, 20264:15 PM ET13G/A6.90%2.80M shares–Dec 31, 2025SEC
ZOOZZOOZ Strategy Ltd.Feb 17, 20264:15 PM ET13G8.60%13.9M sharesNewDec 31, 2025SEC
CNNECannae Holdings, Inc.Feb 17, 20264:15 PM ET13G/A7.60%3.55M shares+1.50 ppfrom 6.10%Dec 31, 2025SEC
FLWS1 800 Flowers Com IncFeb 17, 20264:15 PM ET13G/A9.60%3.50M shares+1.50 ppfrom 8.10%Dec 31, 2025SEC
TBPHTheravance Biopharma, Inc.Feb 17, 20264:15 PM ET13G/A8.50%4.30M shares−1.20 ppfrom 9.70%Dec 31, 2025SEC
NVRIEnviri CorpFeb 17, 20264:15 PM ET13G6.20%5.00M sharesNewDec 31, 2025SEC
AIVApartment Investment & Management CoNov 14, 20254:05 PM ET13G5.50%7.76M sharesNewSep 30, 2025SEC
CNNECannae Holdings, Inc.Nov 14, 20254:05 PM ET13G/A6.10%3.41M shares−1.20 ppfrom 7.30%Sep 30, 2025SEC